Elicio Therapeutics, Inc.

Healthcare

NASDAQ:ELTX · NASDAQ Global Market

Market Cap $73.48M Beta 1.14 P/E (TTM) -1.7

$3.85 -18.90%

-$0.89 today

52W Low $2.66High $16.00

Vol 5.37M · Avg 0.34M

EPS (TTM) -$2.21Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-52.00%

Period High

$14.85

Period Low

$2.76

Latest

$3.85

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nkarta, Inc.

NASDAQ:NKTX

$195.68M

Molecular Partners AG

NASDAQ:MOLN

$147.61M

PepGen Inc.

NASDAQ:PEPG

$124.27M

Milestone Pharmaceuticals Inc.

NASDAQ:MIST

$112.40M

Corbus Pharmaceuticals Holdings, Inc.

NASDAQ:CRBP

$102.98M

Cardiff Oncology, Inc.

NASDAQ:CRDF

$83.07M

Cassava Sciences, Inc.

SAVA

$63.77M

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

$50.60M

Actuate Therapeutics Inc

NASDAQ:ACTU

$49.41M

Applied Therapeutics, Inc.

APLT

$14.86M

What is the latest ELTX filing?

The latest filing shown is 8-K dated Jun 17, 2026.

How many recent filings does ELTX have?

Intrinsic Alpha currently shows 20 recent filings for ELTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.